What does Zhejiang Hisoar Pharmaceutical Co., Ltd. do?

Zhejiang Hisoar Pharmaceutical Co., Ltd. (002099.SZ) operates in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.

What is 002099.SZ's market cap?

Zhejiang Hisoar Pharmaceutical Co., Ltd. (002099.SZ) has a market capitalization of approximately $8.43 billion, as of August 26, 2026, based on the most recent share price and shares outstanding.

Does 002099.SZ pay a dividend?

Yes — Zhejiang Hisoar Pharmaceutical Co., Ltd. (002099.SZ) has a dividend payment history. The most recent payment, frequency, and full history are on the Dividend tab.

Is 002099.SZ profitable?

Zhejiang Hisoar Pharmaceutical Co., Ltd. (002099.SZ) currently reports negative earnings on a trailing-twelve-month basis. The Earnings and Financials tabs show the full EPS history, revenue trend, and analyst forecasts for future profitability.

002099.SZ

Zhejiang Hisoar Pharmaceutical Co., Ltd.

SHZ·Drug Manufacturers, Specialty & Generic · Healthcare

¥5.21¥0.02+0.39%

Market cap¥8.43B·Aug 26 7:04 AM UTC

Price Chart

¥5.21+¥0.02 (+0.39%)today

−40.25%CAGR −9.79%

Select date range

FromTo

Dec 25, 2006Aug 26, 2021 → Aug 26, 2026· 5.0 yrsAug 26, 2026

Key Metrics

DividendDividend Tab

Dividend Yield (FWD)0.00%

Annual Dividend (FWD)¥0.00

Dividend Growth (5Y)−12.9%

Dividend Safety—

Payout Ratio—

FCF Payout Ratio—

Most Recent Dividend¥0.050

Ex-Dividend DateMay 24

Payment DateMay 24

EarningsEarnings Tab

EPS (FWD)—

P/E Ratio (FWD)—

EPS Growth (1Y)—

EPS Growth (3Y)−14.0%

EPS Growth (5Y)−39.3%

Next Earnings DateOct 28

Last Report DateApr 28

Reported vs Estimate−¥0.00

Earnings Surprise—

FinancialsFinancials Tab

Revenue¥1.86B

Net Income−¥73.86M

Net Margin−4.0%

Operating Cash Flow−¥77.78M

Capital Expenditures¥65.59M

Free Cash Flow−¥143.37M

Return on Equity−1.5%

Return on Invested Capital0.4%

Net Debt¥539.98M

Value Graph

PRO

See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.

Click below to see what's inside, then upgrade to unlock for 002099.SZ and 80,000+ other tickers.

EPS · Price vs. Fair Value Price Fair

Income Statement Flow

PRO

See exactly how 002099.SZ's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.

The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for 002099.SZ and 80,000+ other tickers.

About Zhejiang Hisoar Pharmaceutical Co., Ltd.

Zhejiang Hisoar Pharmaceutical Co., Ltd. is a pharmaceutical enterprise that specializes in the manufacturing and global distribution of fine chemicals and specialized active pharmaceutical ingredients (APIs). Its diverse product portfolio encompasses materials used in the production of antibiotics, antiviral medications, cardiovascular drugs, and glucose-reducing agents, among others. Beyond these core APIs, the company also supplies pharmaceutical intermediates and provides customized processing services. Key products include clindamycin, the 4-AA Iso-carbapenem series, thiamphenicol…

CEO: Guorui Xu
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Exchange: SHZ
Employees: 2,736
Website: www.hisoar.com

Peers

Peers Tab

000739.SZ

Apeloa Pharmaceutical Co.,Ltd

Cap

¥24.0B

000999.SZ

China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.

Cap

¥40.7B

002019.SZ

Yifan Pharmaceutical Co., Ltd.

Cap

¥12.2B

Latest News

News Tab

No recent news available.

Frequently Asked Questions About 002099.SZ

What does Zhejiang Hisoar Pharmaceutical Co., Ltd. do?: Zhejiang Hisoar Pharmaceutical Co., Ltd. (002099.SZ) operates in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.
What is 002099.SZ's market cap?: Zhejiang Hisoar Pharmaceutical Co., Ltd. (002099.SZ) has a market capitalization of approximately $8.43 billion, as of August 26, 2026, based on the most recent share price and shares outstanding.
Does 002099.SZ pay a dividend?: Yes — Zhejiang Hisoar Pharmaceutical Co., Ltd. (002099.SZ) has a dividend payment history. The most recent payment, frequency, and full history are on the Dividend tab.
Is 002099.SZ profitable?: Zhejiang Hisoar Pharmaceutical Co., Ltd. (002099.SZ) currently reports negative earnings on a trailing-twelve-month basis. The Earnings and Financials tabs show the full EPS history, revenue trend, and analyst forecasts for future profitability.